ArticleCancer genomics & proteomics

ERP44 Is Associated With Poor Prognosis and Promotes Proliferation and Temozolomide Resistance in Lower-grade Glioma.

Lingmin Shao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.